[SCHEDULE 13G/A] cbdMD, Inc. SEC Filing
Rhea-AI Filing Summary
cbdMD, Inc. received an updated ownership report from investor Clark R. Crosnoe and related entities on a passive basis. Crosnoe is reported to beneficially own 436,150 common shares, representing 4.9% of the class, through CRC Investment Fund LP, NM 2018 Trust, and AMC Legacy Trust, all of which show shared voting and dispositive power and no sole power.
CRC Investment Fund LP reports beneficial ownership of 361,400 common shares, or 4.1% of the class. NM 2018 Trust reports 56,875 shares (about 0.6%), and AMC Legacy Trust reports 17,875 shares (about 0.2%). The percentages are calculated based on 8,919,410 common shares outstanding as of November 6, 2025, as disclosed in cbdMD’s Form S-1. Crosnoe disclaims beneficial ownership of securities held by the fund and trusts except to the extent of his pecuniary interest, and certifies that the holdings are not for the purpose of changing or influencing control of cbdMD.
Positive
- None.
Negative
- None.
FAQ
What ownership stake does Clark R. Crosnoe report in cbdMD (YCBD)?
Clark R. Crosnoe reports beneficial ownership of 436,150 cbdMD common shares, representing 4.9% of the outstanding common stock, with shared voting and dispositive power over these shares.
What stakes do the NM 2018 Trust and AMC Legacy Trust hold in cbdMD (YCBD)?
The NM 2018 Trust dated April 4, 2018 reports beneficial ownership of 56,875 common shares, or about 0.6% of cbdMD’s common stock. The AMC Legacy Trust dated December 21, 2012 reports 17,875 common shares, or about 0.2% of the class.
How does Clark R. Crosnoe describe his beneficial ownership of cbdMD (YCBD) through the fund and trusts?
The filing explains that Crosnoe is the sole member of CRC Investment Fund GP, LLC, the general partner of CRC LP, and has investment authority over the NM 2018 Trust and AMC Legacy Trust. He disclaims beneficial ownership of securities directly owned by CRC LP and the trusts except to the extent of his pecuniary interest.